Xiong F - Search Results

1

Correction: Unveiling the role of HP1α-HDAC1-STAT1 axis as a therapeutic target for HP1α-positive intrahepatic cholangiocarcinoma.

Xiong F, Wang D, Xiong W, Wang X, Huang WH, Wu GH, Liu WZ, Wang Q, Chen JS, Kuai YY, Wang B, Chen YJ. Xiong F, et al. Among authors: xiong w. J Exp Clin Cancer Res. 2024 Jul 5;43(1):186. doi: 10.1186/s13046-024-03112-w. J Exp Clin Cancer Res. 2024. PMID: 38965576 Free PMC article. No abstract available.

2

CyclinD1 inhibits dicer and crucial miRNA expression by chromatin modification to promote the progression of intrahepatic cholangiocarcinoma.

Qi Y, Wang D, Huang W, Wang B, Huang D, Xiong F, Chen X, Chen Y. Qi Y, et al. Among authors: xiong f. J Exp Clin Cancer Res. 2019 Oct 7;38(1):413. doi: 10.1186/s13046-019-1415-5. J Exp Clin Cancer Res. 2019. PMID: 31590696 Free PMC article.

3

Plastin-3 is a diagnostic and prognostic marker for pancreatic adenocarcinoma and distinguishes from diffuse large B-cell lymphoma.

Xiong F, Wu GH, Wang B, Chen YJ. Xiong F, et al. Cancer Cell Int. 2021 Aug 4;21(1):411. doi: 10.1186/s12935-021-02117-1. Cancer Cell Int. 2021. PMID: 34348730 Free PMC article.

4

Advances in the DNA methylation hydroxylase TET1.

Liu W, Wu G, Xiong F, Chen Y. Liu W, et al. Among authors: xiong f. Biomark Res. 2021 Oct 16;9(1):76. doi: 10.1186/s40364-021-00331-7. Biomark Res. 2021. PMID: 34656178 Free PMC article. Review.

5

MiR-155-5p suppresses SOX1 to promote proliferation of cholangiocarcinoma via RAF/MEK/ERK pathway.

Wang D, Xiong F, Wu G, Liu W, Wang B, Chen Y. Wang D, et al. Among authors: xiong f. Cancer Cell Int. 2021 Dec 7;21(1):656. doi: 10.1186/s12935-021-02374-0. Cancer Cell Int. 2021. PMID: 34876142 Free PMC article.

6

Keratin 8 Is an Inflammation-Induced and Prognosis-Related Marker for Pancreatic Adenocarcinoma.

Xiong F, Guo T, Wang X, Wu G, Liu W, Wang Q, Wang B, Chen Y. Xiong F, et al. Dis Markers. 2022 Jul 27;2022:8159537. doi: 10.1155/2022/8159537. eCollection 2022. Dis Markers. 2022. PMID: 35958278 Free PMC article.

7

Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow.

Xiong F, Wang Q, Wu GH, Liu WZ, Wang B, Chen YJ. Xiong F, et al. Biomark Res. 2022 Sep 14;10(1):69. doi: 10.1186/s40364-022-00415-y. Biomark Res. 2022. PMID: 36104718 Free PMC article. Review.

8

HOXA5 inhibits the proliferation of extrahepatic cholangiocarcinoma cells by enhancing MXD1 expression and activating the p53 pathway.

Xiong F, Liu W, Wang X, Wu G, Wang Q, Guo T, Huang W, Wang B, Chen Y. Xiong F, et al. Cell Death Dis. 2022 Sep 27;13(9):829. doi: 10.1038/s41419-022-05279-6. Cell Death Dis. 2022. PMID: 36167790 Free PMC article.

9

Preliminary comparison of total laparoscopic and open radical resection for hepatic hilar cholangiocarcinoma a single-center cohort study.

Xiong F, Peng F, Li X, Chen Y. Xiong F, et al. Asian J Surg. 2023 Feb;46(2):856-862. doi: 10.1016/j.asjsur.2022.07.158. Epub 2022 Oct 4. Asian J Surg. 2023. PMID: 36207210 Free article.

10

The H2A.Z-KDM1A complex promotes tumorigenesis by localizing in the nucleus to promote SFRP1 promoter methylation in cholangiocarcinoma cells.

Wang Q, Qi Y, Xiong F, Wang D, Wang B, Chen Y. Wang Q, et al. Among authors: xiong f. BMC Cancer. 2022 Nov 11;22(1):1166. doi: 10.1186/s12885-022-10279-y. BMC Cancer. 2022. PMID: 36368958 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,862 results

Search Page

Filters